eISSN : 2146-9369
Creative Commons Lisansı
Journal of Clinical and Experimental Investigations is licenced under the terms of Creative Commons Attribution-Non Commercial4.0 International (CC BY-NC 4.0) License.
Abstract - Middle East Respiratory Syndrome: MERS
Emine Parlak

Emine Parlak

Atatürk University, Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Erzurum, Turkey

Middle East Respiratory Syndrome: MERS

Emine Parlak

Atatürk University, Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Erzurum, Turkey

ABSTRACT

Middle East respiratory syndrome coronavirus (MERS-CoV) is a newly emerging respiratory virus. It was first identified in Saudi Arabia in 2012. MERS-CoV infection is characterized by a spectrum of illness ranging from mild to acute and fulminant disease. The majority of patients present with fever, fever with chills/rigors, cough, shortness of breath, and dry cough. Cases of human-to-human transmission have been documented. There is currently no specific treatment and vaccination for MERS-CoV infection. Surveillance and infection-control measures are of vital importance to an ef­ficient public health response. J Microbiol Infect Dis 2015;5(2): 93-98

Emine Parlak, Atatürk University, Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Erzurum, Turkey, Middle East Respiratory Syndrome: MERS, Emine Parlak, Atatürk University, Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Erzurum, Turkey J Microbiol Infect Dis 2015; 5(2): 93-98 doi: 10.5799/ahinjs.02.2015.02.0184

Volume 05, Number 02 (2015)

Volume 05, Number 02 (2015)